Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Final Results of a Phase Ib/II Randomized Study and Single-Arm Extension (Ext) Study

Sehn L. H., Hertzberg M., Opat S., Herrera A. F., Assouline S., Flowers C. R., ...More

64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, United States Of America, 10 - 13 December 2022, pp.9464-9467, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Doi Number: 10.1182/blood-2022-157679
  • City: Louisiana
  • Country: United States Of America
  • Page Numbers: pp.9464-9467
  • Ankara University Affiliated: Yes